Our Approach and Expertise

The Multidisciplinary Melanoma Treatment Program of NewYork-Presbyterian Hospital offers comprehensive treatment services for cutaneous, ocular, and mucosal melanoma. Center Director Bret Taback, MD (surgical oncology) leads a multidisciplinary team with expertise in:

  • surgical oncology
  • dermatologic surgery
  • medical oncology
  • radiation oncology
  • dermatopathology
  • oculoplastic surgery
  • immunotherapy
  • head and neck surgery
  • plastic and reconstructive surgery
  • nurses dedicated to the treatment of melanoma

The Center's comprehensive, coordinated patient services include:

  • screening
  • MoleMap (full body scan) technology for high risk patients
  • radiation treatment, gamma knife surgery
  • excisional surgery, sentinel lymph node biopsy, and other appropriate surgical procedures
  • Interleukin-2 (IL-2) treatment (immunotherapy)
  • clinical trials for promising treatments of melanoma

The IL-2 Unit of NewYork-Presbyterian/Columbia University Medical Center treats patients using interleukin-2 (IL-2), an approved therapy for the treatment of malignant melanoma and kidney cancer. The only academic, comprehensive, high-dose IL-2 center in New York City, our multidisciplinary unit consists of dedicated and specially trained physicians, nurses, pharmacists, social workers, and nutritionists.

To refer a patient to the Melanoma Center, or for more information about the program, please contact Bret Taback, MD at 855.CUSURGE.